Literature DB >> 15320909

Development of granulomatous common variable immunodeficiency subsequent to infection with Toxoplasma gondii.

S Mrusek1, A Marx, J Kummerle-Deschner, N Tzaribachev, A Enders, U-N Riede, K Warnatz, G E Dannecker, S Ehl.   

Abstract

Common variable immunodeficiency (CVID) is a heterogeneous immunodeficiency that is accompanied by granulomatous lesions in 5-10% of cases. Why some patients develop granulomatous disease remains unclear. Here we describe a 12-year-old previously healthy girl who presented with pancytopenia and granulomatous lymphoproliferation subsequent to infection with Toxoplasma gondii. Loosely arranged non-fibrosing granulomas were observed in the liver, lymph nodes and lung, but no Toxoplasma tachyzoites could be demonstrated and polymerase chain reaction (PCR) and culture were negative for Toxoplasma and a wide range of other pathogens. While the patient had a normal peripheral B cell status at presentation, the development of CVID could be observed during the following months, leading to a loss of memory B cells. This was accompanied by an increasingly activated CD4(+) T cell compartment and high serum levels of angiotensin-converting enzyme (ACE), tumour necrosis factor (TNF) and sCD25. Steroid therapy reduced pancytopenia, granulomatous lymphoproliferation and cytokine elevations, but did not improve the B cell status. This is the first report of an association of Toxoplasma infection with granulomatous CVID and provides one of the rare examples where the onset of CVID could be documented subsequent to an infectious disease.

Entities:  

Mesh:

Year:  2004        PMID: 15320909      PMCID: PMC1809154          DOI: 10.1111/j.1365-2249.2004.02558.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Fine mapping of IGAD1 in IgA deficiency and common variable immunodeficiency: identification and characterization of haplotypes shared by affected members of 101 multiple-case families.

Authors:  I Vorechovský; M Cullen; M Carrington; L Hammarström; A D Webster
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

2.  Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome.

Authors:  M Morra; O Silander; S Calpe; M Choi; H Oettgen; L Myers; A Etzioni; R Buckley; C Terhorst
Journal:  Blood       Date:  2001-09-01       Impact factor: 22.113

3.  Reversible monoclonal lymphadenopathy in autoimmune lymphoproliferative syndrome with functional FAS (CD95/APO-1) deficiency.

Authors:  P Ströbel; R Nanan; S Gattenlöhner; S Müller-Deubert; H K Müller-Hermelink; H W Kreth; A Marx
Journal:  Am J Surg Pathol       Date:  1999-07       Impact factor: 6.394

Review 4.  Human genetic defects in class-switch recombination (hyper-IgM syndromes).

Authors:  A Durandy; T Honjo
Journal:  Curr Opin Immunol       Date:  2001-10       Impact factor: 7.486

5.  The simultaneous presentation of sarcoidosis and common variable immune deficiency.

Authors:  R Ameratunga; D M Becroft; W Hunter
Journal:  Pathology       Date:  2000-11       Impact factor: 5.306

Review 6.  Noncaseating granulomatous disease in common variable immunodeficiency.

Authors:  N Kanathur; R P Byrd; C L Fields; T M Roy
Journal:  South Med J       Date:  2000-06       Impact factor: 0.954

7.  Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease.

Authors:  Klaus Warnatz; Axel Denz; Ruth Dräger; Moritz Braun; Christoph Groth; Guido Wolff-Vorbeck; Hermann Eibel; Michael Schlesier; Hans Hartmut Peter
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

8.  Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency.

Authors:  Bodo Grimbacher; Andreas Hutloff; Michael Schlesier; Erik Glocker; Klaus Warnatz; Ruth Dräger; Hermann Eibel; Beate Fischer; Alejandro A Schäffer; Hans W Mages; Richard A Kroczek; Hans H Peter
Journal:  Nat Immunol       Date:  2003-02-10       Impact factor: 25.606

9.  Familial combined cellular and humoral immune defect with multisystem granulomata.

Authors:  W H Perks; I S Petheram
Journal:  Thorax       Date:  1978-02       Impact factor: 9.139

10.  Mutations of the X-linked lymphoproliferative disease gene SH2D1A mimicking common variable immunodeficiency.

Authors:  Annarosa Soresina; Vassilis Lougaris; Silvia Giliani; Fabio Cardinale; Lucio Armenio; Marco Cattalini; Luigi D Notarangelo; Alessandro Plebani
Journal:  Eur J Pediatr       Date:  2002-10-23       Impact factor: 3.183

View more
  10 in total

1.  Ill-defined germinal centers and severely reduced plasma cells are histological hallmarks of lymphadenopathy in patients with common variable immunodeficiency.

Authors:  Susanne Unger; Maximilian Seidl; Annette Schmitt-Graeff; Joachim Böhm; Klaudia Schrenk; Claudia Wehr; Sigune Goldacker; Ruth Dräger; Barbara C Gärtner; Paul Fisch; Martin Werner; Klaus Warnatz
Journal:  J Clin Immunol       Date:  2014-05-02       Impact factor: 8.317

2.  Granulomatous skin lesions complicating Varicella infection in a patient with Rothmund-Thomson syndrome and immune deficiency: case report.

Authors:  Lien De Somer; Carine Wouters; Marie-Anne Morren; Rita De Vos; Joost Van Den Oord; Koenraad Devriendt; Isabelle Meyts
Journal:  Orphanet J Rare Dis       Date:  2010-12-08       Impact factor: 4.123

3.  Cerebral toxoplasmosis in a patient with combined variable immunodeficiency.

Authors:  Torrey Czech; Parthav Shah; Gunnar Lee; Gina Watanabe; Christian Ogasawara; Thomas Noh
Journal:  Surg Neurol Int       Date:  2022-08-12

4.  Granulomatous disease in common variable immunodeficiency.

Authors:  Omür Ardeniz; Charlotte Cunningham-Rundles
Journal:  Clin Immunol       Date:  2009-08-28       Impact factor: 3.969

Review 5.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

Review 6.  Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients.

Authors:  Jean-Nicolas Boursiquot; Laurence Gérard; Marion Malphettes; Claire Fieschi; Lionel Galicier; David Boutboul; Raphael Borie; Jean-François Viallard; Pauline Soulas-Sprauel; Alice Berezne; Arnaud Jaccard; Eric Hachulla; Julien Haroche; Nicolas Schleinitz; Laurent Têtu; Eric Oksenhendler
Journal:  J Clin Immunol       Date:  2012-09-18       Impact factor: 8.317

7.  Case report and review of the literature: Toxoplasma gondii encephalitis in a 40-year-old woman with common variable immunodeficiency and a new diagnosis of large granular lymphocytic leukemia.

Authors:  Adam Hofmann; Gerasimos Zaharatos; Mark Miller
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-07       Impact factor: 2.471

Review 8.  Granulomatous disease in common variable immunodeficiency.

Authors:  Yoshikazu Morimoto; John M Routes
Journal:  Curr Allergy Asthma Rep       Date:  2005-09       Impact factor: 4.919

9.  What Works When Treating Granulomatous Disease in Genetically Undefined CVID? A Systematic Review.

Authors:  Astrid C van Stigt; Willem A Dik; Lieke S J Kamphuis; Bas M Smits; Joris M van Montfrans; P Martin van Hagen; Virgil A S H Dalm; Hanna IJspeert
Journal:  Front Immunol       Date:  2020-12-17       Impact factor: 7.561

10.  The critical role of histology in distinguishing sarcoidosis from common variable immunodeficiency disorder (CVID) in a patient with hypogammaglobulinemia.

Authors:  Rohan Ameratunga; Yeri Ahn; Dominic Tse; See-Tarn Woon; Jennifer Pereira; Sinead McCarthy; Hilary Blacklock
Journal:  Allergy Asthma Clin Immunol       Date:  2019-12-02       Impact factor: 3.406

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.